Paradigm unlocks $40M loan – and sees a 75cps price not far away
Paradigm Biopharmaceuticals (ASX:PAR) shares were up nearly +25% in morning trades as the company unveiled a loan of around $41 million to advance its osteoarthritis clinical investigations.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from thr...
The Watchlist
Previous Video
Next Video
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online